Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people

BACKGROUND: Several SARS-CoV-2 vaccines have shown clinical efficacy against Covid-19 infection but there remains uncertainty about the immune responses elicited by different regimens. This is a particularly important question for older people who are at increased clinical risk following infection a...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, Helen, Bruton, Rachel, Stephens, Christine, Brown, Kevin, Amirthalingam, Gayatri, Otter, Ashley, Hallis, Bassam, Zuo, Jianmin, Moss, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377354/
https://www.ncbi.nlm.nih.gov/pubmed/34416887
http://dx.doi.org/10.1186/s12979-021-00246-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377354/
https://www.ncbi.nlm.nih.gov/pubmed/34416887
http://dx.doi.org/10.1186/s12979-021-00246-9

Ejemplares similares